Dr. Ehud (Udi) Netzer is named Chairman at HIL. Dr. Netzer joined HIL’s Board of Directors last year and was today appointed by HIL’s Board

We’re on the Map! HIL featured in The Marker Magazine STARTUP NATION HIGH-TECH MAP: The Marker magazine tells the story of HIL Medical and its unique Proton Therapy

HIL at JP Morgan Healthcare Conference – the CICC Israel Lounge   HIL will partake in the CICC’s Israel Lounge, on January 13-14th, during the JP Morgan

HIL awarded €2.5M in grant funding by the EU The European Commission managing Horizon 2020 – the EU Framework Programme for Research and Innovation –

Dr. Raphael Pfeffer, Assuta Chief Of Oncology and HIL Advisory Board Member, in an interview on the future of radiation therapy  For its Medicine 2020

Dr. Ehud (Udi) Netzer joins HIL’s Board of Directors Dr. Netzer is a seasoned technology leader with over 35 years of experience covering all phases

HIL and CERN announce collaboration (and Globes coverage) Novel technologies developed at CERN could be used in HIL’s system, helping to further reduce the size

HIL and Hebrew University announce new R&D and manufacturing facility in Jerusalem Calcalist, one of Israel’s leading financial news outlets, published HIL’s plan to set

HIL recognized in Israel’s Personal Medicine / Longevity industry 2019 report HIL is featured as one of 160 companies in the Aging Analytics Agency and